Photos: P&G Voluntarily Recalls Specific Lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom

CINCINNATI, November 19 - The Procter & Gamble Company (NYSE: PG) announced today it is voluntarily
recalling three lots of its Vicks Sinex nasal spray in three countries: the
United States, Germany and the United Kingdom.

To view the Multimedia News Release, go to:
multivu.prnewswire.com/mnr/pg/41327/

The company said it is taking this precautionary step after finding the
bacteria B. cepacia in a small amount of product made at its plant in Gross
Gerau, Germany. There have been no reports of illness. However, the bacteria
could cause serious infections for individuals with a compromised immune
system, or those with chronic lung conditions, such as cystic fibrosis. B.
cepacia poses little medical risk to healthy individuals.

P&G detected this problem during routine quality control at the plant and
promptly took action. The company's analysis to date shows this problem is
limited to a single batch of raw material mixture involving three lots of
product. These three lots were sold only in the United States, Germany and
the United Kingdom.

The lot numbers of the products involved are:

       Lot #        Country                 Product Name
    9239028831    United States       Vicks Sinex Vapospray 12-Hour
                                       Decongestant Ultra Fine Mist, 15 ml.,
                                       Nasal Spray
    9224028832    United Kingdom      Vicks Sinex Micromist Aqueous Nasal
                                       Spray Solution, 15 ml
    9224028833    Germany             Wick Sinex Schnupfenspray Dosiersystem,
                                       15 ml

This lot number is listed on both the outer carton and the bottle.
Consumers should simply discard the affected product as they would any OTC
medicine.

P&G is removing the product in question from store shelves and has
informed regulatory authorities in the affected countries. P&G said it found
the bacteria B. cepacia in a small amount of product from U.S. lot 9239028831
and is conducting testing on the U.K. and German lots that have been produced
from the same batch of raw material mixture.

Anyone who has these specific lots of this product can call P&G for a
replacement coupon or refund at the following numbers:

From the United States, please call: 1-877-876-7881 (Hours of operation:
Monday - Friday, 9AM - 6PM US ET, Saturday - Sunday, 9AM - 4PM US ET)

From the United Kingdom, please call: 0800-5555-15 (Hours of operation:
19 November, 4PM - 9PM local time and will continue Monday - Friday, 8AM -
6PM local time, Saturday - Sunday, 9AM - 5PM local time)

From Germany, please call: 0800-111-6131 (Hours of operation: 19
November, 4PM - 9PM local time and will continue Monday - Friday, 8AM - 6PM
local time, Saturday - Sunday, 9AM - 5PM local time)

For U.S. Consumers

Any adverse events with the use of this product and/or quality problems
in the United States should be reported via the FDA's MedWatch Program by fax
at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane,
Rockville, MD 20852-9787, or on the MedWatch Web site at
www.fda.gov/medwatch.

About Procter & Gamble

Four billion times a day, P&G brands touch the lives of people around the
world. The company has one of the strongest portfolios of trusted, quality,
leadership brands, including Pampers(R), Tide(R), Ariel(R), Always(R),
Whisper(R), Pantene(R), Mach3(R), Bounty(R), Dawn(R), Gain(R), Pringles(R),
Charmin(R), Downy(R), Lenor(R), Iams(R), Crest(R), Oral-B(R), Duracell(R),
Olay(R), Head & Shoulders(R), Wella(R), Gillette(R), Braun(R) and Fusion(R).
The P&G community includes approximately 135,000 employees working in about
80 countries worldwide. Please visit www.pg.com for the latest news
and in-depth information about P&G and its brands.

U.S. Media, Tom Millikin, +1-513-622-1522, millikin.tm at pg.com, Paul Fox, +1-513-884-2592, fox.pd at pg.com; U.K. Media, Lee Bansil, +44-7780-223895, bansil.l at pg.com; German Media, Andrea Riepe, +49-172-302-3253, riepe.a at pg.com